PerkinElmer, Inc. has signed a definitive agreement to acquire molecular imaging and detection solutions provider Caliper Life Sciences, Inc. for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
Send this story to:
Enter the email address of the recipient.Separate multiple addresses with commas.
Add your own personal message:
Enter your email address:
Note: Your email address is used only to let the recipient
know who sent the story, and in case of transmission error.
Both your address and the recipient's address will not be
used for any other purpose.